Skip to main content

Dube Eric M's Form 4 filing

Travere Therapeutics, Inc. (TVTX) · filed Oct 30, 2025

Accession no.
0001763494-25-000005
Filed
Oct 30, 2025
Trade date
Oct 28-29, 2025
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $3.64M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Dube Eric MCIK 0001763494Director, Officer (CHIEF EXECUTIVE OFFICER)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 28, 2025Common StockMOption exerciseAcquired+92,872$15.46+$1,435,801.12512,045Direct
Oct 28, 2025Common StockSSaleDisposed−92,872$30.38−$2,821,451.36419,173Direct
Oct 29, 2025Common StockMOption exerciseAcquired+27,128$15.46+$419,398.88446,301Direct
Oct 29, 2025Common StockSSaleDisposed−27,128$30.12−$817,095.36419,173Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Oct 28, 2025Common StockMOption exerciseDisposed−92,872$0.00$0207,128Direct
Oct 29, 2025Common StockMOption exerciseDisposed−27,128$0.00$0180,000Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)